Back
Larimar Therapeutics Vs. Prime Medicine Industry Stock Comparison
Sell
38
LRMR
Larimar Therapeutics
Last Price:
6.85
Seasonality Move:
-2.11%
Sell
22
PRME
Prime Medicine
Last Price:
3.99
Seasonality Move:
-25.18%
Sell
38
Larimar Therapeutics (LRMR)
is a Sell
Is Larimar Therapeutics a Buy, Sell or Hold?
- The current Larimar Therapeutics [LRMR] share price is $6.81. The Score for LRMR is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- LRMR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
Prime Medicine (PRME)
is a Sell
Is Prime Medicine a Buy, Sell or Hold?
- The current Prime Medicine [PRME] share price is $4.00. The Score for PRME is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- PRME is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LRMR Stock Price Chart
What is Larimar Therapeutics's stock price today?
-
The Larimar Therapeutics share price today is $6.81
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LRMR is experiencing buying pressure, which is a positive indicator for future bullish movement.
PRME Stock Price Chart
What is Prime Medicine's stock price today?
-
The Prime Medicine share price today is $4.00
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRME is experiencing slight buying pressure.
LRMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.28 | Sell |
Relative Strength Index (14 RSI): | 40.45 | Sell |
Chaikin Money Flow: | 302776 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.24 - 8.16) | Sell |
Bollinger Bands (100): | (7.13 - 9.09) | Sell |
PRME Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.22 | Sell |
Relative Strength Index (14 RSI): | 45.22 | Sell |
Chaikin Money Flow: | 198344 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.87 - 4.39) | Sell |
Bollinger Bands (100): | (4.34 - 6.58) | Sell |
LRMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.36 | Sell |
20-day SMA: | 7.7 | Sell |
50-day SMA: | 8.31 | Sell |
200-day SMA: | 7.48 | Sell |
8-day EMA: | 7.25 | Sell |
20-day EMA: | 7.59 | Sell |
50-day EMA: | 7.92 | Sell |
200-day EMA: | 7.32 | Sell |
PRME Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.9 | Buy |
20-day SMA: | 4.08 | Sell |
50-day SMA: | 4.73 | Sell |
200-day SMA: | 6.45 | Sell |
8-day EMA: | 3.95 | Buy |
20-day EMA: | 4.1 | Sell |
50-day EMA: | 4.62 | Sell |
200-day EMA: | 6.6 | Sell |
Larimar Therapeutics Earnings Growth & LRMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.15 per share, a decrease this year of $0.69 per share, and a decrease next year of $0.43 per share.
Prime Medicine Earnings Growth & PRME Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.13 per share, an increase this year of $0.17 per share, and an increase next year of $0.21 per share.
Larimar Therapeutics Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Prime Medicine Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |